Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-12-24

AUTHORS

S. Vasikaran, R. Eastell, O. Bruyère, A. J. Foldes, P. Garnero, A. Griesmacher, M. McClung, H. A. Morris, S. Silverman, T. Trenti, D. A. Wahl, C. Cooper, J. A. Kanis, for the IOF-IFCC Bone Marker Standards Working Group

ABSTRACT

The International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) recommend that a marker of bone formation (serum procollagen type I N propeptide, s-PINP) and a marker of bone resorption (serum C-terminal telopeptide of type I collagen, s-CTX) are used as reference analytes for bone turnover markers in clinical studies.IntroductionBone turnover markers (BTM) predict fracture risk, and treatment-induced changes in specific markers account for a substantial proportion of fracture risk reduction. The aims of this report were to determine their clinical potential in the prediction of fracture risk and for monitoring the treatment of osteoporosis and to set an appropriate research agenda.MethodsEvidence from prospective studies was gathered through literature review of the PUBMED database between the years 2000 and 2010 and the systematic review of the Agency for Healthcare Research and Quality up to 2001.ResultsHigh levels of BTMs may predict fracture risk independently from bone mineral density in postmenopausal women. They have been used for this purpose in clinical practice for many years, but there is still a need for stronger evidence on which to base practice. BTMs provide pharmacodynamic information on the response to osteoporosis treatment, and as a result, they are widely used for monitoring treatment in the individual. However, their clinical value for monitoring is limited by inadequate appreciation of the sources of variability, by limited data for comparison of treatments using the same BTM and by inadequate quality control. IOF/IFCC recommend one bone formation marker (s-PINP) and one bone resorption marker (s-CTX) to be used as reference markers and measured by standardised assays in observational and intervention studies in order to compare the performance of alternatives and to enlarge the international experience of the application of markers to clinical medicine.ConclusionBTM hold promise in fracture risk prediction and for monitoring treatment. Uncertainties over their clinical use can be in part resolved by adopting international reference standards. More... »

PAGES

391-420

References to SciGraph publications

  • 2008-05-10. Determinants of Bone Turnover Markers in Healthy Premenopausal Women in CALCIFIED TISSUE INTERNATIONAL
  • 2000-02. Predictors of Fractures in Elderly Women in OSTEOPOROSIS INTERNATIONAL
  • 2000-01. Serum Bone Alkaline Phosphatase and Calcaneus Bone Density Predict Fractures: A Prospective Study in OSTEOPOROSIS INTERNATIONAL
  • 2010-06-09. The utility of BMD Z-score diagnostic thresholds for secondary causes of osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 2000-03. Risk Factors for Perimenopausal Fractures: A Prospective Study in OSTEOPOROSIS INTERNATIONAL
  • 2005-12-15. Changes in bone mass and bone turnover following tibial shaft fracture in OSTEOPOROSIS INTERNATIONAL
  • 2004-04-08. Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study in OSTEOPOROSIS INTERNATIONAL
  • 2009-06-11. FRAX® assessment of osteoporotic fracture probability in Switzerland in OSTEOPOROSIS INTERNATIONAL
  • 2009-10-08. Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years in OSTEOPOROSIS INTERNATIONAL
  • 1991-02. Potential risk factors for development of postmenopausal osteoporosis — Examined over a 12-year period in OSTEOPOROSIS INTERNATIONAL
  • 2002-07. Biochemical Indices of Bone Turnover and the Assessment of Fracture Probability in OSTEOPOROSIS INTERNATIONAL
  • 2002-07. A New Approach to the Development of Assessment Guidelines for Osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 1996-04. Bone density change and biochemical indices of skeletal turnover in CALCIFIED TISSUE INTERNATIONAL
  • 1981-12. Mean wall thickness and formation periods of trabecular bone packets in idiopathic osteoporosis in CALCIFIED TISSUE INTERNATIONAL
  • 2000-12. Preanalytical Variability of Biochemical Markers of Bone Turnover in OSTEOPOROSIS INTERNATIONAL
  • 2008-02-22. Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™) in OSTEOPOROSIS INTERNATIONAL
  • 2000-12. The Use of Biochemical Markers of Bone Turnover in Osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 1995-08. Evolution of spinal bone loss and biochemical markers of bone remodeling after menopause in normal women in CALCIFIED TISSUE INTERNATIONAL
  • 2001-11. Six and Twelve Month Changes in Bone Turnover are Related to Reduction in Vertebral Fracture Risk During 3 Years of Raloxifene Treatment in Postmenopausal Osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 1990-10. Screening procedure for women at risk of developing postmenopausal osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 2006-08-16. An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 1998-05. Association Between Female Sex Hormones and Biochemical Markers of Bone Turnover in Peri- and Postmenopausal Women in CALCIFIED TISSUE INTERNATIONAL
  • 2008-02-12. European guidance for the diagnosis and management of osteoporosis in postmenopausal women in OSTEOPOROSIS INTERNATIONAL
  • 2009-05-13. Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover in OSTEOPOROSIS INTERNATIONAL
  • 2008-07-16. Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 2009-02-04. Bone turnover markers: understanding their value in clinical trials and clinical practice in OSTEOPOROSIS INTERNATIONAL
  • 2009-11-25. Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study in OSTEOPOROSIS INTERNATIONAL
  • 2004-12-24. Requirements for DXA for the management of osteoporosis in Europe in OSTEOPOROSIS INTERNATIONAL
  • Journal

    TITLE

    Osteoporosis International

    ISSUE

    2

    VOLUME

    22

    Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00198-010-1501-1

    DOI

    http://dx.doi.org/10.1007/s00198-010-1501-1

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1044145841

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/21184054


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged, 80 and over", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Algorithms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biomarkers", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bone Density", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bone Remodeling", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Osteoporosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Osteoporosis, Postmenopausal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Osteoporotic Fractures", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Reference Standards", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Risk Assessment", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Treatment Outcome", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "School of Pathology and Laboratory Medicine, University of Western Australia, Nedlands, WA, Australia", 
              "id": "http://www.grid.ac/institutes/grid.1012.2", 
              "name": [
                "Department of Core Clinical Pathology and Biochemistry, PathWest Laboratory Medicine, Royal Perth Hospital, Perth, WA, Australia", 
                "School of Pathology and Laboratory Medicine, University of Western Australia, Nedlands, WA, Australia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Vasikaran", 
            "givenName": "S.", 
            "id": "sg:person.01175332754.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175332754.44"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Centre for Biomedical Research, Northern General Hospital, Herries Road, S5 7AU, Sheffield, South Yorkshire, England, UK", 
              "id": "http://www.grid.ac/institutes/grid.412937.a", 
              "name": [
                "Centre for Biomedical Research, Northern General Hospital, Herries Road, S5 7AU, Sheffield, South Yorkshire, England, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Eastell", 
            "givenName": "R.", 
            "id": "sg:person.0100521534.43", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0100521534.43"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Public Health, Epidemiology and Health Economics, University of Li\u00e8ge, Li\u00e8ge, Belgium", 
              "id": "http://www.grid.ac/institutes/grid.4861.b", 
              "name": [
                "Department of Public Health, Epidemiology and Health Economics, University of Li\u00e8ge, Li\u00e8ge, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bruy\u00e8re", 
            "givenName": "O.", 
            "id": "sg:person.01234306547.54", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234306547.54"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Osteoporosis Center, Hadassah University Hospital, Mount Scopus, 91240, Jerusalem, Israel", 
              "id": "http://www.grid.ac/institutes/grid.17788.31", 
              "name": [
                "Osteoporosis Center, Hadassah University Hospital, Mount Scopus, 91240, Jerusalem, Israel"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Foldes", 
            "givenName": "A. J.", 
            "id": "sg:person.01351040403.82", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351040403.82"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "INSERM Unit 664, Lyon, France", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "INSERM Unit 664, Lyon, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Garnero", 
            "givenName": "P.", 
            "id": "sg:person.01337464403.01", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337464403.01"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, 6080, Innsbruck, Austria", 
              "id": "http://www.grid.ac/institutes/grid.410706.4", 
              "name": [
                "Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, 6080, Innsbruck, Austria"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Griesmacher", 
            "givenName": "A.", 
            "id": "sg:person.0653325641.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653325641.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Oregon Osteoporosis Center, 5050 NE Hoyt Street, Suite 651, 97213, Portland, OR, USA", 
              "id": "http://www.grid.ac/institutes/grid.240531.1", 
              "name": [
                "Oregon Osteoporosis Center, 5050 NE Hoyt Street, Suite 651, 97213, Portland, OR, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McClung", 
            "givenName": "M.", 
            "id": "sg:person.01202365465.00", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202365465.00"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "School of Pharmacy and Medical Sciences, University of South Australia, 5000, Adelaide, SA, Australia", 
              "id": "http://www.grid.ac/institutes/grid.1026.5", 
              "name": [
                "School of Pharmacy and Medical Sciences, University of South Australia, 5000, Adelaide, SA, Australia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Morris", 
            "givenName": "H. A.", 
            "id": "sg:person.01030064305.01", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030064305.01"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cedars-Sinai/University of California, Los Angeles, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.19006.3e", 
              "name": [
                "Cedars-Sinai/University of California, Los Angeles, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Silverman", 
            "givenName": "S.", 
            "id": "sg:person.0750301114.52", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750301114.52"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Patologia Clinica, Tossicologia e Diagnostica Avanzata, Dipartimento di Patologia Clinica, Ospedale Nuovo Sant\u2019Agostino Estense, via Giardini 1355, 4110, Modena, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Patologia Clinica, Tossicologia e Diagnostica Avanzata, Dipartimento di Patologia Clinica, Ospedale Nuovo Sant\u2019Agostino Estense, via Giardini 1355, 4110, Modena, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Trenti", 
            "givenName": "T.", 
            "id": "sg:person.016305713433.58", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016305713433.58"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "International Osteoporosis Foundation, Nyon, Switzerland", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "International Osteoporosis Foundation, Nyon, Switzerland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wahl", 
            "givenName": "D. A.", 
            "id": "sg:person.0622727433.54", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622727433.54"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "NIHR Musculoskeletal Biomedical Research Unit, Institute of Musculoskeletal Sciences, University of Oxford, OX3 7LD, Oxford, UK", 
              "id": "http://www.grid.ac/institutes/grid.4991.5", 
              "name": [
                "MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, SO16 6YD, Southampton, UK", 
                "NIHR Musculoskeletal Biomedical Research Unit, Institute of Musculoskeletal Sciences, University of Oxford, OX3 7LD, Oxford, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cooper", 
            "givenName": "C.", 
            "id": "sg:person.01154357674.52", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154357674.52"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Centre for Metabolic Bone Diseases (WHO Collaborating Centre), University of Sheffield Medical School, Beech Hill Road, S10 2RX, Sheffield, UK", 
              "id": "http://www.grid.ac/institutes/grid.11835.3e", 
              "name": [
                "Centre for Metabolic Bone Diseases (WHO Collaborating Centre), University of Sheffield Medical School, Beech Hill Road, S10 2RX, Sheffield, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kanis", 
            "givenName": "J. A.", 
            "id": "sg:person.0663427426.32", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663427426.32"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "for the IOF-IFCC Bone Marker Standards Working Group", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s001980050009", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042493026", 
              "https://doi.org/10.1007/s001980050009"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980070004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022005652", 
              "https://doi.org/10.1007/s001980070004"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01880450", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002944999", 
              "https://doi.org/10.1007/bf01880450"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980200068", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043812640", 
              "https://doi.org/10.1007/s001980200068"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-009-0838-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014340593", 
              "https://doi.org/10.1007/s00198-009-0838-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02409438", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047093168", 
              "https://doi.org/10.1007/bf02409438"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-009-0975-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013633075", 
              "https://doi.org/10.1007/s00198-009-0975-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-005-2025-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052259550", 
              "https://doi.org/10.1007/s00198-005-2025-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-008-0560-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000501834", 
              "https://doi.org/10.1007/s00198-008-0560-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-004-1602-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036604057", 
              "https://doi.org/10.1007/s00198-004-1602-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-007-0544-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021197386", 
              "https://doi.org/10.1007/s00198-007-0544-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01880414", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032171571", 
              "https://doi.org/10.1007/bf01880414"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-009-1078-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017865228", 
              "https://doi.org/10.1007/s00198-009-1078-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002239900450", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017259414", 
              "https://doi.org/10.1007/s002239900450"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-010-1307-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025923527", 
              "https://doi.org/10.1007/s00198-010-1307-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00298429", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000963044", 
              "https://doi.org/10.1007/bf00298429"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-004-1811-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033148553", 
              "https://doi.org/10.1007/s00198-004-1811-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-008-0660-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002143137", 
              "https://doi.org/10.1007/s00198-008-0660-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980070002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025267804", 
              "https://doi.org/10.1007/s001980070002"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-009-1127-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000441845", 
              "https://doi.org/10.1007/s00198-009-1127-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00228-006-0174-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017268550", 
              "https://doi.org/10.1007/s00228-006-0174-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980170020", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051252526", 
              "https://doi.org/10.1007/s001980170020"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/pl00004174", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020210098", 
              "https://doi.org/10.1007/pl00004174"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-009-0940-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026001642", 
              "https://doi.org/10.1007/s00198-009-0940-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00223-008-9126-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009110185", 
              "https://doi.org/10.1007/s00223-008-9126-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980050284", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020074736", 
              "https://doi.org/10.1007/s001980050284"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02508642", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041509001", 
              "https://doi.org/10.1007/bf02508642"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980200069", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001135478", 
              "https://doi.org/10.1007/s001980200069"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2010-12-24", 
        "datePublishedReg": "2010-12-24", 
        "description": "The International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) recommend that a marker of bone formation (serum procollagen type I N propeptide, s-PINP) and a marker of bone resorption (serum C-terminal telopeptide of type I collagen, s-CTX) are used as reference analytes for bone turnover markers in clinical studies.IntroductionBone turnover markers (BTM) predict fracture risk, and treatment-induced changes in specific markers account for a substantial proportion of fracture risk reduction. The aims of this report were to determine their clinical potential in the prediction of fracture risk and for monitoring the treatment of osteoporosis and to set an appropriate research agenda.MethodsEvidence from prospective studies was gathered through literature review of the PUBMED database between the years 2000 and 2010 and the systematic review of the Agency for Healthcare Research and Quality up to 2001.ResultsHigh levels of BTMs may predict fracture risk independently from bone mineral density in postmenopausal women. They have been used for this purpose in clinical practice for many years, but there is still a need for stronger evidence on which to base practice. BTMs provide pharmacodynamic information on the response to osteoporosis treatment, and as a result, they are widely used for monitoring treatment in the individual. However, their clinical value for monitoring is limited by inadequate appreciation of the sources of variability, by limited data for comparison of treatments using the same BTM and by inadequate quality control. IOF/IFCC recommend one bone formation marker (s-PINP) and one bone resorption marker (s-CTX) to be used as reference markers and measured by standardised assays in observational and intervention studies in order to compare the performance of alternatives and to enlarge the international experience of the application of markers to clinical medicine.ConclusionBTM hold promise in fracture risk prediction and for monitoring treatment. Uncertainties over their clinical use can be in part resolved by adopting international reference standards.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s00198-010-1501-1", 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2783241", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1100834", 
            "issn": [
              "0937-941X", 
              "1433-2965"
            ], 
            "name": "Osteoporosis International", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "2", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "22"
          }
        ], 
        "keywords": [
          "International Osteoporosis Foundation", 
          "fracture risk", 
          "turnover markers", 
          "osteoporosis treatment", 
          "fracture risk reduction", 
          "bone turnover markers", 
          "bone resorption markers", 
          "bone formation markers", 
          "treatment of osteoporosis", 
          "bone mineral density", 
          "reference standard", 
          "international reference standards", 
          "treatment-induced changes", 
          "IntroductionBone turnover markers", 
          "fracture risk prediction", 
          "comparison of treatments", 
          "postmenopausal women", 
          "resorption markers", 
          "prospective study", 
          "formation markers", 
          "bone turnover", 
          "bone resorption", 
          "mineral density", 
          "clinical studies", 
          "clinical value", 
          "clinical practice", 
          "pharmacodynamic information", 
          "PubMed database", 
          "intervention studies", 
          "systematic review", 
          "clinical use", 
          "Healthcare Research", 
          "clinical potential", 
          "bone formation", 
          "specific markers", 
          "risk prediction", 
          "standardised assays", 
          "substantial proportion", 
          "International Federation", 
          "limited data", 
          "treatment", 
          "risk reduction", 
          "risk", 
          "markers", 
          "clinical chemistry", 
          "clinical medicine", 
          "hold promise", 
          "appropriate research agenda", 
          "literature review", 
          "laboratory medicine", 
          "medicine", 
          "review", 
          "osteoporosis", 
          "reference markers", 
          "strong evidence", 
          "resorption", 
          "inadequate quality control", 
          "MethodsEvidence", 
          "year 2000", 
          "BTM", 
          "women", 
          "study", 
          "report", 
          "sources of variability", 
          "assays", 
          "application of marker", 
          "aim", 
          "years", 
          "proportion", 
          "inadequate appreciation", 
          "monitoring", 
          "need", 
          "individuals", 
          "practice", 
          "response", 
          "evidence", 
          "levels", 
          "database", 
          "control", 
          "standards", 
          "reduction", 
          "turnover", 
          "IFCC", 
          "experience", 
          "changes", 
          "use", 
          "promise", 
          "purpose", 
          "quality control", 
          "data", 
          "quality", 
          "alternative", 
          "potential", 
          "comparison", 
          "variability", 
          "research agenda", 
          "results", 
          "reference analytes", 
          "appreciation", 
          "part", 
          "information", 
          "Federation", 
          "values", 
          "research", 
          "agencies", 
          "formation", 
          "prediction", 
          "BTMS", 
          "international experience", 
          "source", 
          "order", 
          "density", 
          "analytes", 
          "foundation", 
          "agenda", 
          "applications", 
          "performance", 
          "uncertainty", 
          "chemistry", 
          "performance of alternatives"
        ], 
        "name": "Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards", 
        "pagination": "391-420", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1044145841"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00198-010-1501-1"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "21184054"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00198-010-1501-1", 
          "https://app.dimensions.ai/details/publication/pub.1044145841"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:28", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_513.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s00198-010-1501-1"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00198-010-1501-1'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00198-010-1501-1'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00198-010-1501-1'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00198-010-1501-1'


     

    This table displays all metadata directly associated to this object as RDF triples.

    487 TRIPLES      21 PREDICATES      190 URIs      154 LITERALS      24 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00198-010-1501-1 schema:about N04b814f731014fb4af49120af5e7e352
    2 N20f5ef261d1d43288939422744e4fb78
    3 N2a530aeeac1d4629b9f60cd32d6e4742
    4 N47f6430ec477476a9e9d9955ad435789
    5 N4886b530dcf54951b34f0e6b0ce0bea8
    6 N6614e4a9d9e84f409de50119f0e911d8
    7 N76ff50886f7b44c697849ff4b337c8d3
    8 N803b7abab645454e964564164c513778
    9 N8c831954f55f4b6bb11e276b2ea99494
    10 Naa933da9863f493f95bbf59902bb0693
    11 Nbb3bc7da16484925b4808a255077c9f2
    12 Nbcccdb1a343b4b9d982aad0a8e2b0516
    13 Ndadff1ca4cd2499cac825b67eecb9f43
    14 Ne22001ab024d4528a232c2fd73fc587c
    15 Nf829086e38bf427d9cd4fa05dcae2f97
    16 Nfe7be4d0ec8d4403bac457d61455c021
    17 Nff29fd9e7acf4b07b73e2a2367f7c95b
    18 anzsrc-for:11
    19 anzsrc-for:1103
    20 schema:author Na7d1efe6b41a4f7298ceefeb831f1d1e
    21 schema:citation sg:pub.10.1007/bf00298429
    22 sg:pub.10.1007/bf01880414
    23 sg:pub.10.1007/bf01880450
    24 sg:pub.10.1007/bf02409438
    25 sg:pub.10.1007/bf02508642
    26 sg:pub.10.1007/pl00004174
    27 sg:pub.10.1007/s00198-004-1602-9
    28 sg:pub.10.1007/s00198-004-1811-2
    29 sg:pub.10.1007/s00198-005-2025-y
    30 sg:pub.10.1007/s00198-007-0544-4
    31 sg:pub.10.1007/s00198-008-0560-z
    32 sg:pub.10.1007/s00198-008-0660-9
    33 sg:pub.10.1007/s00198-009-0838-9
    34 sg:pub.10.1007/s00198-009-0940-z
    35 sg:pub.10.1007/s00198-009-0975-1
    36 sg:pub.10.1007/s00198-009-1078-8
    37 sg:pub.10.1007/s00198-009-1127-3
    38 sg:pub.10.1007/s00198-010-1307-1
    39 sg:pub.10.1007/s001980050009
    40 sg:pub.10.1007/s001980050284
    41 sg:pub.10.1007/s001980070002
    42 sg:pub.10.1007/s001980070004
    43 sg:pub.10.1007/s001980170020
    44 sg:pub.10.1007/s001980200068
    45 sg:pub.10.1007/s001980200069
    46 sg:pub.10.1007/s00223-008-9126-5
    47 sg:pub.10.1007/s002239900450
    48 sg:pub.10.1007/s00228-006-0174-3
    49 schema:datePublished 2010-12-24
    50 schema:datePublishedReg 2010-12-24
    51 schema:description The International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) recommend that a marker of bone formation (serum procollagen type I N propeptide, s-PINP) and a marker of bone resorption (serum C-terminal telopeptide of type I collagen, s-CTX) are used as reference analytes for bone turnover markers in clinical studies.IntroductionBone turnover markers (BTM) predict fracture risk, and treatment-induced changes in specific markers account for a substantial proportion of fracture risk reduction. The aims of this report were to determine their clinical potential in the prediction of fracture risk and for monitoring the treatment of osteoporosis and to set an appropriate research agenda.MethodsEvidence from prospective studies was gathered through literature review of the PUBMED database between the years 2000 and 2010 and the systematic review of the Agency for Healthcare Research and Quality up to 2001.ResultsHigh levels of BTMs may predict fracture risk independently from bone mineral density in postmenopausal women. They have been used for this purpose in clinical practice for many years, but there is still a need for stronger evidence on which to base practice. BTMs provide pharmacodynamic information on the response to osteoporosis treatment, and as a result, they are widely used for monitoring treatment in the individual. However, their clinical value for monitoring is limited by inadequate appreciation of the sources of variability, by limited data for comparison of treatments using the same BTM and by inadequate quality control. IOF/IFCC recommend one bone formation marker (s-PINP) and one bone resorption marker (s-CTX) to be used as reference markers and measured by standardised assays in observational and intervention studies in order to compare the performance of alternatives and to enlarge the international experience of the application of markers to clinical medicine.ConclusionBTM hold promise in fracture risk prediction and for monitoring treatment. Uncertainties over their clinical use can be in part resolved by adopting international reference standards.
    52 schema:genre article
    53 schema:isAccessibleForFree false
    54 schema:isPartOf N67cdcf945ac44f098423fdd123d2a7ef
    55 N70c2583b52484592a69b9903aae06c7b
    56 sg:journal.1100834
    57 schema:keywords BTM
    58 BTMS
    59 Federation
    60 Healthcare Research
    61 IFCC
    62 International Federation
    63 International Osteoporosis Foundation
    64 IntroductionBone turnover markers
    65 MethodsEvidence
    66 PubMed database
    67 agencies
    68 agenda
    69 aim
    70 alternative
    71 analytes
    72 application of marker
    73 applications
    74 appreciation
    75 appropriate research agenda
    76 assays
    77 bone formation
    78 bone formation markers
    79 bone mineral density
    80 bone resorption
    81 bone resorption markers
    82 bone turnover
    83 bone turnover markers
    84 changes
    85 chemistry
    86 clinical chemistry
    87 clinical medicine
    88 clinical potential
    89 clinical practice
    90 clinical studies
    91 clinical use
    92 clinical value
    93 comparison
    94 comparison of treatments
    95 control
    96 data
    97 database
    98 density
    99 evidence
    100 experience
    101 formation
    102 formation markers
    103 foundation
    104 fracture risk
    105 fracture risk prediction
    106 fracture risk reduction
    107 hold promise
    108 inadequate appreciation
    109 inadequate quality control
    110 individuals
    111 information
    112 international experience
    113 international reference standards
    114 intervention studies
    115 laboratory medicine
    116 levels
    117 limited data
    118 literature review
    119 markers
    120 medicine
    121 mineral density
    122 monitoring
    123 need
    124 order
    125 osteoporosis
    126 osteoporosis treatment
    127 part
    128 performance
    129 performance of alternatives
    130 pharmacodynamic information
    131 postmenopausal women
    132 potential
    133 practice
    134 prediction
    135 promise
    136 proportion
    137 prospective study
    138 purpose
    139 quality
    140 quality control
    141 reduction
    142 reference analytes
    143 reference markers
    144 reference standard
    145 report
    146 research
    147 research agenda
    148 resorption
    149 resorption markers
    150 response
    151 results
    152 review
    153 risk
    154 risk prediction
    155 risk reduction
    156 source
    157 sources of variability
    158 specific markers
    159 standardised assays
    160 standards
    161 strong evidence
    162 study
    163 substantial proportion
    164 systematic review
    165 treatment
    166 treatment of osteoporosis
    167 treatment-induced changes
    168 turnover
    169 turnover markers
    170 uncertainty
    171 use
    172 values
    173 variability
    174 women
    175 year 2000
    176 years
    177 schema:name Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
    178 schema:pagination 391-420
    179 schema:productId N30c30c2f09344d57bfc419f08e40997e
    180 N538df721229b40889fd371c525a0b93b
    181 Nd5f38d53e4024963a1377597bb10c9ff
    182 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044145841
    183 https://doi.org/10.1007/s00198-010-1501-1
    184 schema:sdDatePublished 2022-12-01T06:28
    185 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    186 schema:sdPublisher N0f9cb1e9dcb74c45971270a6c0b5e619
    187 schema:url https://doi.org/10.1007/s00198-010-1501-1
    188 sgo:license sg:explorer/license/
    189 sgo:sdDataset articles
    190 rdf:type schema:ScholarlyArticle
    191 N04b814f731014fb4af49120af5e7e352 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    192 schema:name Humans
    193 rdf:type schema:DefinedTerm
    194 N0f9cb1e9dcb74c45971270a6c0b5e619 schema:name Springer Nature - SN SciGraph project
    195 rdf:type schema:Organization
    196 N16cc195243254d8ca3f5e5b924c6e22a rdf:first sg:person.0622727433.54
    197 rdf:rest N7a05f2a9c6e3446f92d5dbd1d29eaeb4
    198 N20f5ef261d1d43288939422744e4fb78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    199 schema:name Treatment Outcome
    200 rdf:type schema:DefinedTerm
    201 N21f76729c96f4c5cad0728f05b99c9cf rdf:first sg:person.01202365465.00
    202 rdf:rest Nba57ccac5e654d65bab40aaebe893a64
    203 N22d1fbf820d84ffa95a256da683d810e rdf:first sg:person.016305713433.58
    204 rdf:rest N16cc195243254d8ca3f5e5b924c6e22a
    205 N27bb12ee351d4f00beea69729e4b8c38 rdf:first sg:person.01337464403.01
    206 rdf:rest Nb39e3adc56924130a28c9de0af0761d4
    207 N2a530aeeac1d4629b9f60cd32d6e4742 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    208 schema:name Algorithms
    209 rdf:type schema:DefinedTerm
    210 N30c30c2f09344d57bfc419f08e40997e schema:name doi
    211 schema:value 10.1007/s00198-010-1501-1
    212 rdf:type schema:PropertyValue
    213 N47f6430ec477476a9e9d9955ad435789 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    214 schema:name Female
    215 rdf:type schema:DefinedTerm
    216 N4886b530dcf54951b34f0e6b0ce0bea8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    217 schema:name Osteoporotic Fractures
    218 rdf:type schema:DefinedTerm
    219 N538df721229b40889fd371c525a0b93b schema:name pubmed_id
    220 schema:value 21184054
    221 rdf:type schema:PropertyValue
    222 N57fd9293600a4655a5b381492ecb8fd8 rdf:first sg:person.01351040403.82
    223 rdf:rest N27bb12ee351d4f00beea69729e4b8c38
    224 N6614e4a9d9e84f409de50119f0e911d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    225 schema:name Risk Assessment
    226 rdf:type schema:DefinedTerm
    227 N6708f2d8d0e74ab0b9a31406c41753f3 rdf:first sg:person.0750301114.52
    228 rdf:rest N22d1fbf820d84ffa95a256da683d810e
    229 N67cdcf945ac44f098423fdd123d2a7ef schema:issueNumber 2
    230 rdf:type schema:PublicationIssue
    231 N70c2583b52484592a69b9903aae06c7b schema:volumeNumber 22
    232 rdf:type schema:PublicationVolume
    233 N76ff50886f7b44c697849ff4b337c8d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    234 schema:name Aged
    235 rdf:type schema:DefinedTerm
    236 N7a05f2a9c6e3446f92d5dbd1d29eaeb4 rdf:first sg:person.01154357674.52
    237 rdf:rest Nc66c2ec8b46e4bc9b1de3b0e64d66a37
    238 N7f322224d7224b24ba12588b3531fbfe rdf:first Ndddfdf8a230b46e28bb05fdbc38b71f7
    239 rdf:rest rdf:nil
    240 N803b7abab645454e964564164c513778 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    241 schema:name Middle Aged
    242 rdf:type schema:DefinedTerm
    243 N8c831954f55f4b6bb11e276b2ea99494 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    244 schema:name Reference Standards
    245 rdf:type schema:DefinedTerm
    246 N91db5fa14a8b4c5489384e2a900032b5 rdf:first sg:person.01234306547.54
    247 rdf:rest N57fd9293600a4655a5b381492ecb8fd8
    248 Na7d1efe6b41a4f7298ceefeb831f1d1e rdf:first sg:person.01175332754.44
    249 rdf:rest Nda8e398993a64f3fae54cb429d2cc025
    250 Naa933da9863f493f95bbf59902bb0693 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    251 schema:name Osteoporosis, Postmenopausal
    252 rdf:type schema:DefinedTerm
    253 Nb39e3adc56924130a28c9de0af0761d4 rdf:first sg:person.0653325641.42
    254 rdf:rest N21f76729c96f4c5cad0728f05b99c9cf
    255 Nba57ccac5e654d65bab40aaebe893a64 rdf:first sg:person.01030064305.01
    256 rdf:rest N6708f2d8d0e74ab0b9a31406c41753f3
    257 Nbb3bc7da16484925b4808a255077c9f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    258 schema:name Adult
    259 rdf:type schema:DefinedTerm
    260 Nbcccdb1a343b4b9d982aad0a8e2b0516 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    261 schema:name Aged, 80 and over
    262 rdf:type schema:DefinedTerm
    263 Nc66c2ec8b46e4bc9b1de3b0e64d66a37 rdf:first sg:person.0663427426.32
    264 rdf:rest N7f322224d7224b24ba12588b3531fbfe
    265 Nd5f38d53e4024963a1377597bb10c9ff schema:name dimensions_id
    266 schema:value pub.1044145841
    267 rdf:type schema:PropertyValue
    268 Nda8e398993a64f3fae54cb429d2cc025 rdf:first sg:person.0100521534.43
    269 rdf:rest N91db5fa14a8b4c5489384e2a900032b5
    270 Ndadff1ca4cd2499cac825b67eecb9f43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    271 schema:name Osteoporosis
    272 rdf:type schema:DefinedTerm
    273 Ndddfdf8a230b46e28bb05fdbc38b71f7 schema:familyName for the IOF-IFCC Bone Marker Standards Working Group
    274 rdf:type schema:Person
    275 Ne22001ab024d4528a232c2fd73fc587c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    276 schema:name Bone Density
    277 rdf:type schema:DefinedTerm
    278 Nf829086e38bf427d9cd4fa05dcae2f97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    279 schema:name Male
    280 rdf:type schema:DefinedTerm
    281 Nfe7be4d0ec8d4403bac457d61455c021 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    282 schema:name Biomarkers
    283 rdf:type schema:DefinedTerm
    284 Nff29fd9e7acf4b07b73e2a2367f7c95b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    285 schema:name Bone Remodeling
    286 rdf:type schema:DefinedTerm
    287 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    288 schema:name Medical and Health Sciences
    289 rdf:type schema:DefinedTerm
    290 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    291 schema:name Clinical Sciences
    292 rdf:type schema:DefinedTerm
    293 sg:grant.2783241 http://pending.schema.org/fundedItem sg:pub.10.1007/s00198-010-1501-1
    294 rdf:type schema:MonetaryGrant
    295 sg:journal.1100834 schema:issn 0937-941X
    296 1433-2965
    297 schema:name Osteoporosis International
    298 schema:publisher Springer Nature
    299 rdf:type schema:Periodical
    300 sg:person.0100521534.43 schema:affiliation grid-institutes:grid.412937.a
    301 schema:familyName Eastell
    302 schema:givenName R.
    303 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0100521534.43
    304 rdf:type schema:Person
    305 sg:person.01030064305.01 schema:affiliation grid-institutes:grid.1026.5
    306 schema:familyName Morris
    307 schema:givenName H. A.
    308 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030064305.01
    309 rdf:type schema:Person
    310 sg:person.01154357674.52 schema:affiliation grid-institutes:grid.4991.5
    311 schema:familyName Cooper
    312 schema:givenName C.
    313 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154357674.52
    314 rdf:type schema:Person
    315 sg:person.01175332754.44 schema:affiliation grid-institutes:grid.1012.2
    316 schema:familyName Vasikaran
    317 schema:givenName S.
    318 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175332754.44
    319 rdf:type schema:Person
    320 sg:person.01202365465.00 schema:affiliation grid-institutes:grid.240531.1
    321 schema:familyName McClung
    322 schema:givenName M.
    323 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202365465.00
    324 rdf:type schema:Person
    325 sg:person.01234306547.54 schema:affiliation grid-institutes:grid.4861.b
    326 schema:familyName Bruyère
    327 schema:givenName O.
    328 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234306547.54
    329 rdf:type schema:Person
    330 sg:person.01337464403.01 schema:affiliation grid-institutes:None
    331 schema:familyName Garnero
    332 schema:givenName P.
    333 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337464403.01
    334 rdf:type schema:Person
    335 sg:person.01351040403.82 schema:affiliation grid-institutes:grid.17788.31
    336 schema:familyName Foldes
    337 schema:givenName A. J.
    338 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351040403.82
    339 rdf:type schema:Person
    340 sg:person.016305713433.58 schema:affiliation grid-institutes:None
    341 schema:familyName Trenti
    342 schema:givenName T.
    343 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016305713433.58
    344 rdf:type schema:Person
    345 sg:person.0622727433.54 schema:affiliation grid-institutes:None
    346 schema:familyName Wahl
    347 schema:givenName D. A.
    348 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622727433.54
    349 rdf:type schema:Person
    350 sg:person.0653325641.42 schema:affiliation grid-institutes:grid.410706.4
    351 schema:familyName Griesmacher
    352 schema:givenName A.
    353 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653325641.42
    354 rdf:type schema:Person
    355 sg:person.0663427426.32 schema:affiliation grid-institutes:grid.11835.3e
    356 schema:familyName Kanis
    357 schema:givenName J. A.
    358 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663427426.32
    359 rdf:type schema:Person
    360 sg:person.0750301114.52 schema:affiliation grid-institutes:grid.19006.3e
    361 schema:familyName Silverman
    362 schema:givenName S.
    363 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750301114.52
    364 rdf:type schema:Person
    365 sg:pub.10.1007/bf00298429 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000963044
    366 https://doi.org/10.1007/bf00298429
    367 rdf:type schema:CreativeWork
    368 sg:pub.10.1007/bf01880414 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032171571
    369 https://doi.org/10.1007/bf01880414
    370 rdf:type schema:CreativeWork
    371 sg:pub.10.1007/bf01880450 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002944999
    372 https://doi.org/10.1007/bf01880450
    373 rdf:type schema:CreativeWork
    374 sg:pub.10.1007/bf02409438 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047093168
    375 https://doi.org/10.1007/bf02409438
    376 rdf:type schema:CreativeWork
    377 sg:pub.10.1007/bf02508642 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041509001
    378 https://doi.org/10.1007/bf02508642
    379 rdf:type schema:CreativeWork
    380 sg:pub.10.1007/pl00004174 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020210098
    381 https://doi.org/10.1007/pl00004174
    382 rdf:type schema:CreativeWork
    383 sg:pub.10.1007/s00198-004-1602-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036604057
    384 https://doi.org/10.1007/s00198-004-1602-9
    385 rdf:type schema:CreativeWork
    386 sg:pub.10.1007/s00198-004-1811-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033148553
    387 https://doi.org/10.1007/s00198-004-1811-2
    388 rdf:type schema:CreativeWork
    389 sg:pub.10.1007/s00198-005-2025-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1052259550
    390 https://doi.org/10.1007/s00198-005-2025-y
    391 rdf:type schema:CreativeWork
    392 sg:pub.10.1007/s00198-007-0544-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021197386
    393 https://doi.org/10.1007/s00198-007-0544-4
    394 rdf:type schema:CreativeWork
    395 sg:pub.10.1007/s00198-008-0560-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1000501834
    396 https://doi.org/10.1007/s00198-008-0560-z
    397 rdf:type schema:CreativeWork
    398 sg:pub.10.1007/s00198-008-0660-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002143137
    399 https://doi.org/10.1007/s00198-008-0660-9
    400 rdf:type schema:CreativeWork
    401 sg:pub.10.1007/s00198-009-0838-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014340593
    402 https://doi.org/10.1007/s00198-009-0838-9
    403 rdf:type schema:CreativeWork
    404 sg:pub.10.1007/s00198-009-0940-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1026001642
    405 https://doi.org/10.1007/s00198-009-0940-z
    406 rdf:type schema:CreativeWork
    407 sg:pub.10.1007/s00198-009-0975-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013633075
    408 https://doi.org/10.1007/s00198-009-0975-1
    409 rdf:type schema:CreativeWork
    410 sg:pub.10.1007/s00198-009-1078-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017865228
    411 https://doi.org/10.1007/s00198-009-1078-8
    412 rdf:type schema:CreativeWork
    413 sg:pub.10.1007/s00198-009-1127-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000441845
    414 https://doi.org/10.1007/s00198-009-1127-3
    415 rdf:type schema:CreativeWork
    416 sg:pub.10.1007/s00198-010-1307-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025923527
    417 https://doi.org/10.1007/s00198-010-1307-1
    418 rdf:type schema:CreativeWork
    419 sg:pub.10.1007/s001980050009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042493026
    420 https://doi.org/10.1007/s001980050009
    421 rdf:type schema:CreativeWork
    422 sg:pub.10.1007/s001980050284 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020074736
    423 https://doi.org/10.1007/s001980050284
    424 rdf:type schema:CreativeWork
    425 sg:pub.10.1007/s001980070002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025267804
    426 https://doi.org/10.1007/s001980070002
    427 rdf:type schema:CreativeWork
    428 sg:pub.10.1007/s001980070004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022005652
    429 https://doi.org/10.1007/s001980070004
    430 rdf:type schema:CreativeWork
    431 sg:pub.10.1007/s001980170020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051252526
    432 https://doi.org/10.1007/s001980170020
    433 rdf:type schema:CreativeWork
    434 sg:pub.10.1007/s001980200068 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043812640
    435 https://doi.org/10.1007/s001980200068
    436 rdf:type schema:CreativeWork
    437 sg:pub.10.1007/s001980200069 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001135478
    438 https://doi.org/10.1007/s001980200069
    439 rdf:type schema:CreativeWork
    440 sg:pub.10.1007/s00223-008-9126-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009110185
    441 https://doi.org/10.1007/s00223-008-9126-5
    442 rdf:type schema:CreativeWork
    443 sg:pub.10.1007/s002239900450 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017259414
    444 https://doi.org/10.1007/s002239900450
    445 rdf:type schema:CreativeWork
    446 sg:pub.10.1007/s00228-006-0174-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017268550
    447 https://doi.org/10.1007/s00228-006-0174-3
    448 rdf:type schema:CreativeWork
    449 grid-institutes:None schema:alternateName INSERM Unit 664, Lyon, France
    450 International Osteoporosis Foundation, Nyon, Switzerland
    451 Patologia Clinica, Tossicologia e Diagnostica Avanzata, Dipartimento di Patologia Clinica, Ospedale Nuovo Sant’Agostino Estense, via Giardini 1355, 4110, Modena, Italy
    452 schema:name INSERM Unit 664, Lyon, France
    453 International Osteoporosis Foundation, Nyon, Switzerland
    454 Patologia Clinica, Tossicologia e Diagnostica Avanzata, Dipartimento di Patologia Clinica, Ospedale Nuovo Sant’Agostino Estense, via Giardini 1355, 4110, Modena, Italy
    455 rdf:type schema:Organization
    456 grid-institutes:grid.1012.2 schema:alternateName School of Pathology and Laboratory Medicine, University of Western Australia, Nedlands, WA, Australia
    457 schema:name Department of Core Clinical Pathology and Biochemistry, PathWest Laboratory Medicine, Royal Perth Hospital, Perth, WA, Australia
    458 School of Pathology and Laboratory Medicine, University of Western Australia, Nedlands, WA, Australia
    459 rdf:type schema:Organization
    460 grid-institutes:grid.1026.5 schema:alternateName School of Pharmacy and Medical Sciences, University of South Australia, 5000, Adelaide, SA, Australia
    461 schema:name School of Pharmacy and Medical Sciences, University of South Australia, 5000, Adelaide, SA, Australia
    462 rdf:type schema:Organization
    463 grid-institutes:grid.11835.3e schema:alternateName Centre for Metabolic Bone Diseases (WHO Collaborating Centre), University of Sheffield Medical School, Beech Hill Road, S10 2RX, Sheffield, UK
    464 schema:name Centre for Metabolic Bone Diseases (WHO Collaborating Centre), University of Sheffield Medical School, Beech Hill Road, S10 2RX, Sheffield, UK
    465 rdf:type schema:Organization
    466 grid-institutes:grid.17788.31 schema:alternateName Osteoporosis Center, Hadassah University Hospital, Mount Scopus, 91240, Jerusalem, Israel
    467 schema:name Osteoporosis Center, Hadassah University Hospital, Mount Scopus, 91240, Jerusalem, Israel
    468 rdf:type schema:Organization
    469 grid-institutes:grid.19006.3e schema:alternateName Cedars-Sinai/University of California, Los Angeles, CA, USA
    470 schema:name Cedars-Sinai/University of California, Los Angeles, CA, USA
    471 rdf:type schema:Organization
    472 grid-institutes:grid.240531.1 schema:alternateName Oregon Osteoporosis Center, 5050 NE Hoyt Street, Suite 651, 97213, Portland, OR, USA
    473 schema:name Oregon Osteoporosis Center, 5050 NE Hoyt Street, Suite 651, 97213, Portland, OR, USA
    474 rdf:type schema:Organization
    475 grid-institutes:grid.410706.4 schema:alternateName Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, 6080, Innsbruck, Austria
    476 schema:name Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, 6080, Innsbruck, Austria
    477 rdf:type schema:Organization
    478 grid-institutes:grid.412937.a schema:alternateName Centre for Biomedical Research, Northern General Hospital, Herries Road, S5 7AU, Sheffield, South Yorkshire, England, UK
    479 schema:name Centre for Biomedical Research, Northern General Hospital, Herries Road, S5 7AU, Sheffield, South Yorkshire, England, UK
    480 rdf:type schema:Organization
    481 grid-institutes:grid.4861.b schema:alternateName Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium
    482 schema:name Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium
    483 rdf:type schema:Organization
    484 grid-institutes:grid.4991.5 schema:alternateName NIHR Musculoskeletal Biomedical Research Unit, Institute of Musculoskeletal Sciences, University of Oxford, OX3 7LD, Oxford, UK
    485 schema:name MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, SO16 6YD, Southampton, UK
    486 NIHR Musculoskeletal Biomedical Research Unit, Institute of Musculoskeletal Sciences, University of Oxford, OX3 7LD, Oxford, UK
    487 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...